Immatics N.V. (IMTX)
NASDAQ·Healthcare·Biotechnology
$11.59
+2.11%
Mkt Cap $1.49B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $11.26M | $22.32M | +98.16% | -$0.48 | -$0.34 | +29.17% | — | — |
| Q4 2025 Nov 17, 2025 | $10.71M | $6.08M | -43.26% | -$0.44 | -$0.49 | -11.53% | — | — |
| Q3 2025 Aug 13, 2025 | $12.53M | $5.58M | -55.48% | -$0.38 | -$0.66 | -73.68% | — | — |
| Q2 2025 May 13, 2025 | $13.51M | $20.37M | +50.79% | -$0.39 | -$0.35 | +10.26% | — | — |
| Q1 2025 Mar 27, 2025 | $23.72M | $58.25M | +145.60% | -$0.33 | $0.48 | +245.45% | — | — |
| Q4 2024 Nov 18, 2024 | $16.16M | $55.45M | +243.21% | -$0.27 | -$0.12 | +55.56% | — | — |
| Q3 2024 Aug 13, 2024 | $14.90M | $20.17M | +35.34% | -$0.35 | -$0.18 | +48.57% | — | — |
| Q2 2024 May 14, 2024 | $22.00M | $32.71M | +48.68% | -$0.74 | -$0.04 | +94.59% | — | — |
| Q1 2024 Mar 21, 2024 | $16.37M | $17.51M | +6.96% | -$0.41 | -$0.32 | +21.95% | — | — |
| Q4 2023 Nov 14, 2023 | $15.24M | $6.25M | -58.98% | -$0.42 | -$0.35 | +16.67% | — | — |
| Q3 2023 Aug 17, 2023 | $22.27M | $24.39M | +9.50% | -$0.34 | -$0.35 | -2.94% | — | — |
| Q2 2023 May 16, 2023 | $12.95M | $10.65M | -17.76% | -$0.35 | -$0.28 | +20.00% | — | — |
| Q1 2023 Mar 21, 2023 | $22.69M | $40.55M | +78.73% | $0.17 | -$0.23 | -235.29% | — | — |
| Q4 2022 Nov 17, 2022 | — | $14.71M | — | -$0.31 | -$0.32 | -3.23% | — | — |
| Q3 2022 Aug 9, 2022 | $25.34M | $18.01M | -28.95% | $0.13 | -$0.23 | -276.92% | — | — |
| Q2 2022 Jun 2, 2022 | $158.37M | $113.83M | -28.13% | $1.76 | $1.35 | -23.30% | — | — |
| Q1 2022 Mar 23, 2022 | $10.74M | $17.83M | +65.99% | $1.94 | -$0.30 | -115.46% | — | — |
| Q4 2021 Nov 16, 2021 | $11.94M | $7.48M | -37.38% | -$0.31 | -$0.51 | -64.52% | — | — |
| Q3 2021 Aug 10, 2021 | $10.01M | $6.16M | -38.50% | -$0.38 | -$0.46 | -21.05% | — | — |
| Q2 2021 May 18, 2021 | — | $8.71M | — | -$0.34 | -$0.41 | -20.59% | — | — |